Navigation Links
Cell Pathway May Be Key to Lung Cancer's Spread
Date:7/3/2009

rs used bioinformatics -- the highly complex computer analysis of genetic information -- to study lung tumor samples. They found that the WNT/TCF cell-signaling pathway was the only one of six pathways tested that was hyperactive in lung tumors that went on to metastasize. The pathway was normal in tumors that did not spread. They also observed that WNT/TCF hyperactivity was associated with aggressive tumors and poor survival rates.

"Lung tumors are initiated by mutations in other genes, so we were surprised that a hyperactive WNT pathway would be responsible for metastasis in lung cancer," said the study's senior author, Joan Massague, who chairs Sloan-Kettering's biology and genetics program.

Nguyen said the finding has important implications, including the possible development of therapies that target the pathway.

"There's nothing on the market yet," he said, adding that research will now focus on the weakest links of the pathway for a possible targeted treatment. "The marker can also help physicians decide whether to use more aggressive therapies, such as radiation, earlier in the treatment to help ward off any future metastasis."

Lung cancer is the nation's No. 1 cancer killer, claiming the lives of nearly 200,000 people in the United States each year. There are several forms of the disease, which is usually, but not always, caused by cigarette smoking. Adenocarcinoma forms in the glands that produce mucus and is the most common type of lung cancer in women and among people who have not smoked, according to LungCancer.org. It also spreads rapidly to distant organs, often within months, even if doctors remove the primary tumor.

Survival rates for lung cancer are poor, with only about 15 percent of people with the disease surviving five years. But the researchers hope that their study and others will speed the development of better therapies.

"Our findings suggest that using treatments that target the WN
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Genetic pathway responsible for link between body clock disturbance and worsening arthritis
2. U-M researchers link pathway to breast cancer stem cells
3. Research reveals molecular pathway behind invasive prostate cancers
4. Set out on the Pathway to Change with the Dermatology Nurses Association
5. NPs-NPR-B/pGC-cGMP signal pathway is involved in diabetic gastroparesis
6. Scientists identify gene in breast cancer pathway
7. Pathway Health Services and Vocollect Healthcare Systems Announce Strategic Partnership
8. Pathway to Wisdom May Be Found in Brain Circuitry
9. GPhA Statement on Introduction of H.R. 1548, The Pathway for Biosimilars Act
10. Cell pathway on overdrive prevents cancer response to dietary restriction
11. Exploring new pathways to language

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cell Pathway May Be Key to Lung Cancer's Spread
Cell Pathway May Be Key to Lung Cancer's Spread
(Date:11/7/2009)...id A. Cook (GA), Louis J. Goodman (TX), Palmer P. ...ICAGO, Nov. 7 The Ameri... medical society executive leaders with achievemen... and ideals of the medical profession. The awards ...ing meeting in Houston. ,, (Logo: http://www...
(Date:11/7/2009)...USNewswire/ -- The U.S. bishops November 7 urged m... the Stupak-Ellsworth Amendment to the health care...Dahlkemper-Lipinski-Smith Amendment will keep in p...onscience protections in the Affordable Health Car...he letter was signed by Cardinal Justin Rigali, ch...
(Date:11/7/2009)...roblem across the U.S. , , SATURDAY, Nov. ...our-year colleges do it regularly (and, it,s not s... or more alcoholic drinks at a sitting. , "People ...aid Jenny Hwang, associate dean of students and di...versity on Long Island, N.Y. In fact, she said, he...
(Date:11/6/2009)..., Nov. 6 /PRNewswire-FirstCall/ - Cardiome Pharma ...that it will report financial results for the thir...of Monday, November 9, 2009. Cardiome will hold a ...(6:00am Pacific) on that day to discuss the result...16-695-7806 or 888-789-9572 and reference conferen...
(Date:11/6/2009)...n (NYSE: CNC ) today announced that it will prese... next few weeks. ,, Next week, at the Credit Suiss...ovember 11-13, 2009, at the Arizona Biltmore Resor...ay, November 11th at 4:30 p.m. Mountain Time. Inve...ene,s presentation at: http://w.on24.com/r.htm?e...
Breaking Medicine News(10 mins):Health News:AMA Honors Medical Society Executives 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3Health News:Centene Corporation to Present at Upcoming Healthcare Conferences 2
...ony Ohotto, a physician,with Signature Hospice, ha...ttoo. "Limited life expectancy is no reason not to...e wrote the order as a health clearance, a,stateme... emotional decline in their young patient with a n...
...Long-Time Twin Cities Health Care ...rk G. Mishek, a Minnesota native,with extensive ex... Monday,as President and CEO of Hazelden, the nati...o: http://www.newscom.com/cgi-bin/prnh/20080825/A...
...ecting the expanding,scope of chronic disease care...environmental factors on health care systems and p...blisher Mary Ann Liebert Inc. have renamed,the pee... (Volume 11, Number 4). With the new name comes a,...
...n with certain genotype more affected, study finds...reast-feeding moms who take medicines containing c...eir infant, new Canadian research suggests. , The ... -- possibly harming the infant,s central nervous ...
...ases the risk of developing cancers of the respira...ysis, which the authors say is the first prospecti...rs in the October 1, 2008 issue of CANCER, a pee...rning incensewhich is made of plant materials mixe...
...enefit Group, LLC announces iCan Insurance, LLC (&...w offering major medical health plans from Avalon ...aton, FL (PRWEB) August 24, 2008 -- iCan Benefit G...re, Inc. http://www.icanbenefit.com/majorMedical/...
Other Medicine News:Health News:Signature Hospice Team Grants Patient's Unusual Wish 2Health News:Mark G. Mishek Is New President and CEO of Hazelden 2Health News:Disease Management Journal Changes Name and Expands Focus to Population Health Management 2Health News:Taking Codeine While Breast-Feeding May Harm Infant 2Health News:Taking Codeine While Breast-Feeding May Harm Infant 3Health News:Burning incense increases risk of respiratory tract cancers 2Health News:iCan Benefit Group, LLC Announces: Major Medical Division Now Offers Avalon Healthcare Products 2
(Date:11/6/2009)...anitoba, Nov. 6 With his proposed ...s set his sights on cutting name-brand prescriptio...ho fall into the "Part D" coverage gap, universall...bout the potential cost-cutting and feel it,s a pr...he most powerful lobbyists want a revised program ...
(Date:11/6/2009)...IANGLE PARK, N.C., Nov. 6 Chimerix...ly-available antiviral therapeutics to address lif...evelopment of the company,s lead antiviral compoun...and the Global Health Security Initiative (GHSI). ...developed for the treatment of smallpox, as well a...
(Date:11/6/2009)...Nov. 6 NexBio Inc., in collaborati...rol and Prevention (CDC), St. Louis University, an... publication of two articles in the peer-reviewed ...gest that DAS181 (Fludase ® ) may play a pote...ntion of the Pandemic Influenza A(H1N1) and drug-r...
Breaking Medicine Technology:Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 1Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 2Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 3Studies Show Genetic Activity of Antioxidants 52308 1Studies Show Genetic Activity of Antioxidants 52308 2Studies Show Genetic Activity of Antioxidants 52308 3Winners of the C Everett Koop Health Project Award Announced 52305 1Winners of the C Everett Koop Health Project Award Announced 52305 2
...ging Results for a Potential New Front-Line Treatm...AMBRIDGE, Mass., June 2 Genzyme Corp.,(Nasdaq: G...-enrolled,pivotal, phase 2 study examining the saf...s a single agent in previously untreated, older ad... who are unlikely to benefit,from conventional "7+...
...esponse Trends Suggest Improved Efficacy with High... - Dose Escalation Ongoing -, SAN ...sdaq: MDVN ) today announced that data from an on...vel androgen receptor antagonist,MDV3100, showed e...ining,serum levels of prostate specific antigen (P...
Other Medicine Technology:Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 3Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 4Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 5Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 6Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 7Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 8Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 2Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 3Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 4
Liquichek Autoimmune Controls - Anti-Sm
VARIANTnbs Newborn Hemoglobin Screening System
...ring GmbH, the leading developer of laser diagnost...roduction of the Heidelberg Retina Tomograph 3 (HR...uct for the assessment, diagnosis and management o...ses laser technology to produce a topographical im...
Visante OCT Anterior Segment Imaging and Biometry
Medicine Products: